dehydroepiandrosterone sulfate has been researched along with abiraterone acetate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujisawa, M; Furukawa, J; Harada, K; Hinata, N; Nakano, Y; Sakamoto, M; Suzuki, K; Terakawa, T | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and abiraterone acetate
| Article | Year |
|---|---|
Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate Cancer.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Dehydroepiandrosterone Sulfate; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Rate | 2018 |